Positron emission tomography inter-scanner differences in dopamine D 2 receptor binding measured with [11C]FLB457

Annals of Nuclear Medicine

Volumn 24, Issue 9, 2010, Pages 671-677

  Kodaka, Fumitoshi ^a,b   Ito, Hiroshi ^a   Shidahara, Miho ^a   Takano, Harumasa ^a   Takahashi, Hidehiko ^a   Arakawa, Ryosuke ^a   Nakayama, Kazuhiko ^b   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Binding potential; Brain PET; Inter scanner difference; Simplified reference tissue model

Indexed keywords

CARBON; DIAGNOSTIC AGENT; DOPAMINE 2 RECEPTOR; ISOREMOXIPRIDE; PYRROLIDINE DERIVATIVE; SALICYLAMIDE DERIVATIVE;

ADULT; ARTICLE; ARTIFACT; CLINICAL TRIAL; HUMAN; INSTRUMENTATION; MALE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING;

ADULT; ARTIFACTS; CARBON RADIOISOTOPES; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; YOUNG ADULT;

EID: 79953292313     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-010-0407-5     Document Type: Article

References (20)

1. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-9. (Pubitemid 47301451)
2. Ito H, Hietala J, Blomqvist G, Halldin C, Farde L. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. J Cereb Blood Flow Metab. 1998;18:941-50.
3. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-8.
4. Blomqvist G, Pauli S, Farde L, Eriksson L, Persson A, Halldin C. Maps of receptor binding parameters in the human brain - a kinetic analysis of PET measurements. Eur J Nucl Med. 1990;16:257-65. (Pubitemid 20283537)
5. Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage. 2009;46:154-9.
6. van Velden FH, Kloet RW, van Berckel BN, Buijs FL, Luurtsema G, Lammertsma AA, et al. HRRT versus HR+ human brain PET studies: an Interscanner Test-Retest Study. J Nucl Med. 2009;50:693-702.
7. Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T, et al. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med. 1995;36:1275-81.
8. Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl). 1997;133:396-404. (Pubitemid 27462815)
9. Suhara T, Sudo Y, Okauchi T, Maeda J, Kawabe K, Suzuki K, et al. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmacol. 1999;2:73-82.
10. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B, et al. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab. 1999;19:533-46. (Pubitemid 30159816)
11. Ito H, Sudo Y, Suhara T, Okubo Y, Halldin C, Farde L. Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain. Neuroimage. 2001;13:531-9. (Pubitemid 34185011)
12. Olsson H, Halldin C, Swahn CG, Farde L. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab. 1999;19:1164-73. (Pubitemid 30167767)
13. Matsumoto K, Kitamura K, Mizuta T, Tanaka K, Yamamoto S, Sakamoto S, et al. Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard. J Nucl Med. 2006;47:83-90. (Pubitemid 46768516)
14. Ibaraki M, Sato K, Mizuta T, Kitamura K, Miura S, Sugawara S, et al. Evaluation of dynamic row-action maximum likelihood algorithm reconstruction for quantitative 15O brain PET. Ann Nucl Med. 2009;23:627-38.
15. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med. 1997;38:1614-23. (Pubitemid 27443965)
16. Watson C, Newport D, Casey M. A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans J, editors. Three-dimensional image reconstruction in radiology and nuclear medicine. Dordrecht: Kluwer; 1996. p. 255-68.
17. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-87. (Pubitemid 28018717)
18. Montandon ML, Slosman DO, Zaidi H. Assessment of the impact of model-based scatter correction on [18F]-FDG 3D brain PET in healthy subjects using statistical parametric mapping. Neuroimage. 2003;20:1848-56. (Pubitemid 37468290)
19. Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Physiol Med Biol. 1994;39:411-24. (Pubitemid 24149124)
20. Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, et al. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 2009;45:1107-16.